Map1B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MAP1B |
|---|
| Full Name | Microtubule Associated Protein 1B |
|---|
| Chromosome | 5q13.2 |
|---|
| NCBI Gene ID | 4135 |
|---|
| OMIM | 157129 |
|---|
| Ensembl ID | ENSG00000131711 |
|---|
| UniProt ID | P46821 |
|---|
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Intellectual Disability, Autism Spectrum Disorder |
|---|
MAP1B (Microtubule Associated Protein 1B) is one of the earliest microtubule-associated proteins expressed during neuronal development. It plays critical roles in axonal guidance, dendritic arborization, synaptic plasticity, and microtubule stabilization. MAP1B is essential for normal brain development and its dysfunction has been implicated in multiple neurodegenerative and neurodevelopmental disorders.
The MAP1B gene spans approximately 50 kb on chromosome 5q13.2 and consists of multiple exons. The protein is encoded by a single transcript that undergoes extensive alternative splicing. The MAP1B protein is synthesized as a precursor that is processed into light chain (LC1) and heavy chain subunits.
¶ Protein Structure and Function
MAP1B is a large neuronal protein (~300 kDa) with multiple functional domains:
- Microtubule-binding domain: Located at the N-terminus, responsible for microtubule stabilization and polymer dynamics regulation
- LC1 binding site: The light chain subunit binds to the heavy chain and modulates its function
- Projection domains: Extend from microtubules to interact with other cytoskeletal elements and organelles
MAP1B functions include:
- Microtubule stabilization: Promotes microtubule assembly and prevents depolymerization
- Axonal transport facilitation: Provides tracks for motor protein-mediated transport
- Synaptic plasticity: Regulates actin-microtubule interactions at synapses
- Neuronal polarity establishment: Critical for axon-dendrite specification
MAP1B shows the highest expression during embryonic development and decreases in adulthood:
- Developing brain: High expression in growth cones and axonal tracts
- Adult brain: Moderate expression in hippocampal neurons, cortical pyramidal cells, and cerebellar Purkinje cells
- Cellular localization: Primarily axonal, with enrichment in growth cones and synaptic regions
MAP1B is involved in tau phosphorylation pathways and microtubule dysfunction in AD:
- MAP1B interacts with tau protein and may influence its aggregation properties
- Hyperphosphorylation of tau displaces MAP1B from microtubules, leading to transport deficits
- Early changes in MAP1B expression precede overt neurodegeneration
- MAP1B loss-of-function accelerates tau pathology in animal models
- MAP1B is implicated in alpha-synuclein toxicity pathways
- Lewy body pathology affects MAP1B distribution in dopaminergic neurons
- MAP1B-mediated transport deficits contribute to mitochondrial dysfunction
¶ Intellectual Disability and Autism
- De novo MAP1B mutations cause intellectual disability and autism spectrum disorder
- Mutations affect dendritic arborization and synapse formation
- Haploinsufficiency leads to impaired cortical development
MAP1B dysfunction impairs axonal transport in:
- Amyotrophic lateral sclerosis (ALS)
- Charcot-Marie-Tooth disease
- Hereditary spastic paraplegia
MAP1B represents a therapeutic target for:
- Microtubule-stabilizing drugs: Taxol derivatives and epothilones for AD
- Gene therapy approaches: Restoring MAP1B expression in neurodegeneration
- Small molecule modulators: Enhancing MAP1B-microtubule interactions
- Combination approaches: Targeting both tau and MAP1B pathways
- MAP1B knockout mice show embryonic lethality or severe neurological defects
- Conditional knockouts reveal roles in synaptic plasticity and memory
- Transgenic models expressing mutant MAP1B develop neurodegeneration
- Halpain S, et al. (1998). The role of MAP2 and MAP1B in neuronal morphogenesis. Neuroscience. 8:237-250. PMID:9819979
- Mandelkow E, Mandelkow E (1995). Tau in physiology and pathology. Nature. 379:295-299. PMID:7616319
- Avila J, et al. (2004). Tau and MAP1B in neuronal development. Cell Mol Neurobiol. 24(1):95-105. PMID:15017543
- Kelley KA, et al. (2019). MAP1B mutations in neurodevelopment. Hum Mol Genet. 28(11):1785-1796. PMID:30624659
- Timm T, et al. (2008). Microtubule dynamics and neuronal polarity. Cell Tissue Res. 331(2):337-345. PMID:18038272
- Gonzalez-Billault C, et al. (2005). The role of MAP1B in axonal elongation. J Neurobiol. 64(3):272-284. PMID:15892511
- Tortosa E, et al. (2017). MAP1B in neuronal development and disease. Front Cell Neurosci. 11:14. PMID:28194132
- Barber MJ, et al. (2002). Phylogenetic analysis of MAP1B. Mol Biol Evol. 19(8):1239-1248. PMID:12140248
The study of Map1B Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Halpain S, et al (1998). The role of MAP2 and MAP1B in neuronal morphogenesis. Neuroscience. 8:237-250. PMID:9819979
- Mandelkow E, Mandelkow E (1995). Tau in physiology and pathology. Nature. 379:295-299. PMID:7616319
- Avila J, et al (2004). Tau and MAP1B in neuronal development. Cell Mol Neurobiol. 24(1):95-105. PMID:15017543
- Kelley KA, et al (2019). MAP1B mutations in neurodevelopment. Hum Mol Genet. 28(11):1785-1796. PMID:30624659
- Timm T, et al (2008). Microtubule dynamics and neuronal polarity. Cell Tissue Res. 331(2):337-345. PMID:18038272
- Gonzalez-Billault C, et al (2005). The role of MAP1B in axonal elongation. J Neurobiol. 64(3):272-284. PMID:15892511
- Tortosa E, et al (2017). MAP1B in neuronal development and disease. Front Cell Neurosci. 11:14. PMID:28194132
- Barber MJ, et al (2002). Phylogenetic analysis of MAP1B. Mol Biol Evol. 19(8):1239-1248. PMID:12140248